Clinical Trials Related to Hematologic Cancers

Related studies linked through entity extraction aliases.

Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers

Status: COMPLETED
Phase: PHASE1

Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1

Status: COMPLETED
Phase: PHASE2

Genomic Profiling in Cancer Patients

Status: RECRUITING
Phase: N/A